New technology has potential to accelerate timelines for therapeutic research and drug development SAN DIEGO — Telesis Bio Inc. (OTCMKTS: TBIO), a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced a new license agreement with Regeneron Pharmaceuticals, Inc. to deploy Telesis Bio’s […]
Company to highlight continuous innovation, pharma partnership, and commitment to advancing cancer care through poster presentations and booth demos CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, will showcase some of the technologies that have helped power precision oncology at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. Through […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company’s Chief Technology Officer. Specht, previously vice president of Global R&D for the Chromatography and Mass Spectrometry Division at Thermo Fisher Scientific, will join Agilent on June 9. “We are thrilled to welcome August Specht to the […]
Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular interactions Collaboration allows researchers to progress rapidly from DNA to purified and characterized protein, to facilitate insights into drug-target interactions Showcased at Discovery on Target and PEGS Europe conferences, detailing the production and characterization of […]
Amsbio has expanded its range of high-quality antibodies supporting standardization and Quality Assurance in the fast-growing stem cell research and therapeutic field. These optimized antibodies ensure reliable, accurate results in applications including flow cytometry, immunocytochemistry, Western blot, and ELISA. New additions to the range include monoclonal antibodies against key pluripotent stem cell markers: SSEA-3 (Gb5), SSEA-4 (SialylGb5), and Lewis X (SSEA-1). Stage-Specific Embryonic […]
Fremont, CA – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce a strategic collaboration with SciLifeLab to advance translational proteomics and accelerate biomarker discovery. The partnership brings together Alamar’s NULISA™ technology and ARGO™ HT system—offering ultra-sensitive, multiplexed protein analysis from biofluids—with SciLifeLab’s Proteomics Capabilities and its […]
EMERYVILLE, Calif. – Slingshot Biosciences, a leader in precision-engineered cell mimics, has appointed Glenn Bilawsky as Chief Executive Officer. He succeeds Founder and former CEO Jeffrey Kim, PhD, who will remain actively involved as a Senior Advisor and Board Director. This transition is a strategic inflection point as Slingshot scales to meet rising global demand […]
SAN DIEGO, CA – Bora Biologics, a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, announced a major expansion of its U.S. FDA-registered commercial manufacturing facility in San Diego. This expansion will add state-of-the-art upstream and downstream GMP processing capabilities to meet the increasing demand for 2000L scale single-use biologics manufacturing, solidifying Bora […]
ZURICH — BC Platforms, a technology company pioneering the future of global Real-World Data (RWD) excellence, today announced the appointment of Keith Collier as Chief Product Officer and Michele Lichtenfield as EVP & Head of Global Marketing. Keith and Michele will work with other senior leaders to expand the Company’s global impact and deliver groundbreaking products that redefine the future of scalable and […]
Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced they have received $34.5M in funding, including a strategic investment from Illumina, and structured financing from Soleus Capital and investments from existing investors. Proceeds from this financing will be leveraged to advance Pillar’s commercial activities including headcount and infrastructure to support biopharma partnerships and expand adoption […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
